Allena Pharmaceuticals (Newton, MA) a preclinical-stage biopharmaceutical company focused on nephrologic and urologic conditions, closed a $15M Series A financing. Participants include Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures.